A client diagnosed with herpes simplex virus type 1 is prescribed valacyclovir. Which client statement is correct regarding this medication?

A. "I will be noninfectious while taking this medication.": Valacyclovir helps reduce viral replication and can shorten the duration of symptoms, but it does not eliminate the virus from the body. A client may still shed the virus and remain capable of transmitting HSV-1 to others, even while taking the medication. Safe practices and precautions are still necessary. B. "I must take this medication every day for the rest of my life.": Continuous daily therapy (suppressive therapy) is sometimes prescribed for clients with frequent outbreaks, but it is not required for all patients. Valacyclovir can also be used episodically at the onset of an outbreak, meaning daily lifelong dosing is not universally necessary. C. "This medication will decrease the severity of an outbreak.": Valacyclovir is an antiviral that inhibits viral DNA replication, which reduces the duration, severity, and pain associated with HSV-1 outbreaks. It also helps lesions heal faster and may reduce the frequency of recurrences, making this statement accurate and reflective of its primary therapeutic effect. D. "This medication will cure me of my infection.": There is currently no cure for herpes simplex virus infections. Valacyclovir manages symptoms and viral replication but cannot eradicate the latent virus residing in nerve ganglia. Lifelong viral persistence remains possible, and recurrence can occur.